Pyxis Oncology Inc (PYXS)
3.11
+0.05
(+1.63%)
USD |
NASDAQ |
Jun 26, 11:39
Pyxis Oncology Free Cash Flow: -67.14M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -67.14M |
| December 31, 2023 | -77.44M |
| September 30, 2023 | -81.43M |
| June 30, 2023 | -88.60M |
| March 31, 2023 | -99.16M |
| Date | Value |
|---|---|
| December 31, 2022 | -95.73M |
| September 30, 2022 | -88.66M |
| June 30, 2022 | -71.12M |
| March 31, 2022 | -44.79M |
| December 31, 2021 | -35.87M |
Free Cash Flow Range, Past 5 Years
-99.16M
Minimum
Mar 2023
-35.87M
Maximum
Dec 2021
-74.99M
Average
-79.43M
Median
Free Cash Flow Benchmarks
| Syndax Pharmaceuticals Inc | -204.92M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.71M |
| Cash from Investing (Quarterly) | -18.50M |
| Cash from Financing (Quarterly) | 57.51M |
| Free Cash Flow Per Share (Quarterly) | -0.4084 |
| Free Cash Flow Yield | -49.20% |